Literature DB >> 9444418

Clinicopathological correlations and prognostic factors in lupus nephritis.

F Mitjavila1, V Pac, I Moga, R Poveda, A Vidaller, M Carrera, R Pujol.   

Abstract

OBJECTIVE: To define prognostic factors at the moment of the diagnosis in lupus nephritis, and to assess the contribution of renal histologic data. PATIENTS AND METHODS: Sixty-two patients with systemic lupus erythematosus (SLE) and histologic evidence of nephritis were studied for renal outcome. Correlations between clinical or biological and histological data were carried out as an indicator of the utility of the renal biopsy.
RESULTS: There were no significant differences in creatinine between the different histologic classes at the moment of the diagnosis, although the WHO classification correlated well with proteinuria and immunologic activity. There was a strong correlation between clinical and histological activity as measured by the activity index in proliferative glomerulonephritis, mainly with creatinine and proteinuria, but not with haematuria or immunological activity. Young age at the time of renal biopsy, proliferative classes III and IV, and the chronicity index were associated with a poorer renal prognosis.
CONCLUSIONS: High immunologic activity, mainly elevated anti-DNA titers and decreased levels of CH100, is highly suggestive of proliferative glomerulonephritis. Proliferative classes III and IV and high chronicity indexes are associated with a worse prognosis in lupus nephritis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9444418

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  6 in total

1.  Treatment Results of Patients With Lupus Nephritis: A Single Center's Experience.

Authors:  Cahit Gunes; Mustafa Keles; Abdullah Uyanik; Ramazan Cetinkaya; Refik Ali Sari
Journal:  Eurasian J Med       Date:  2010-12

2.  Is mycophenolate mofetil superior to pulse intravenous cyclophosphamide for induction therapy of proliferative lupus nephritis in Egyptian patients?

Authors:  Eid M El-Shafey; Said H Abdou; Mohamed M Shareef
Journal:  Clin Exp Nephrol       Date:  2010-02-19       Impact factor: 2.801

3.  Efficacy and safety of cyclophosphamide combined with mycophenolate mofetil for induction treatment of class IV lupus nephritis.

Authors:  Jian Sun; Hao Zhang; Ying Ji; Ming Gui; Bin Yi; Jianwen Wang; Juan Jiang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

4.  Idiopathic intracranial hypertension as an initial presentation of systemic lupus erythematosus.

Authors:  Keisha Maloney
Journal:  BMJ Case Rep       Date:  2013-08-13

5.  Clinicopathological correlation in asian patients with biopsy-proven lupus nephritis.

Authors:  Bancha Satirapoj; Pamila Tasanavipas; Ouppatham Supasyndh
Journal:  Int J Nephrol       Date:  2015-03-19

6.  Discovery of NEU1 as a candidatedone. renal biomarker for proliferative lupus nephritis chronicity.

Authors:  Zhaomin Mao; Ying Tan; Feng Yu; Minghui Zhao
Journal:  Lupus Sci Med       Date:  2021-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.